Jane Street’s Exact Sciences EXAS Stock Holding History

Jane Street’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-192,900	Closed	-$19.6M	–	11958
2025 Q4	$19.6M	Buy	192,900 +18,700	+11%	+$1.5M	﹤0.01%	1638
2025 Q3	$9.53M	Sell	174,200 -5,400	-3%	-$270K	﹤0.01%	2493
2025 Q2	$9.54M	Buy	179,600 +6,700	+4%	+$340K	﹤0.01%	2204
2025 Q1	$7.48M	Buy	172,900 +57,800	+50%	+$2.93M	﹤0.01%	2361
2024 Q4	$6.47M	Sell	115,100 -351,900	-75%	-$21.9M	﹤0.01%	2348
2024 Q3	$31.8M	Buy	467,000 +67,100	+17%	+$3.79M	0.01%	941
2024 Q2	$16.9M	Buy	399,900 +32,100	+9%	+$1.77M	﹤0.01%	1473
2024 Q1	$25.4M	Buy	367,800 +257,400	+233%	+$16.3M	0.01%	1012
2023 Q4	$8.17M	Buy	110,400 +35,200	+47%	+$2.31M	﹤0.01%	2196
2023 Q3	$5.13M	Sell	75,200 -35,300	-32%	-$3M	﹤0.01%	2569
2023 Q2	$10.4M	Buy	110,500 +66,900	+153%	+$5.22M	﹤0.01%	1863
2023 Q1	$2.96M	Sell	43,600 -127,500	-75%	-$8.2M	﹤0.01%	3167
2022 Q4	$8.47M	Buy	171,100 +59,200	+53%	+$2.42M	﹤0.01%	1808
2022 Q3	$3.64M	Sell	111,900 -75,200	-40%	-$3.1M	﹤0.01%	3145
2022 Q2	$7.37M	Sell	187,100 -82,600	-31%	-$4.42M	﹤0.01%	2119
2022 Q1	$18.9M	Sell	269,700 -36,500	-12%	-$2.67M	0.01%	1312
2021 Q4	$23.8M	Buy	306,200 +133,000	+77%	+$11.7M	0.01%	1061
2021 Q3	$16.5M	Buy	173,200 +31,700	+22%	+$3.35M	0.01%	1268
2021 Q2	$17.6M	Buy	141,500 +48,500	+52%	+$5.79M	0.01%	1180
2021 Q1	$12.3M	Sell	93,000 -15,900	-15%	-$2.18M	0.01%	1363
2020 Q4	$14.4M	Buy	108,900 +2,900	+3%	+$351K	0.01%	1113
2020 Q3	$10.8M	Sell	106,000 -30,700	-22%	-$2.65M	0.01%	1155
2020 Q2	$11.9M	Buy	136,700 +111,600	+445%	+$8.92M	0.01%	1073
2020 Q1	$1.46M	Sell	25,100 -126,900	-83%	-$10.3M	﹤0.01%	2358
2019 Q4	$14.1M	Buy	152,000 +19,800	+15%	+$1.74M	0.02%	501
2019 Q3	$11.9M	Buy	132,200 +110,400	+506%	+$12.6M	0.02%	514
2019 Q2	$2.57M	Sell	21,800 -49,700	-70%	-$5.01M	﹤0.01%	1631
2019 Q1	$6.19M	Buy	71,500 +8,600	+14%	+$732K	0.01%	985
2018 Q4	$3.97M	Buy	62,900 +44,800	+248%	+$3.07M	0.01%	1092
2018 Q3	$1.43M	Sell	18,100 -37,000	-67%	-$2.41M	﹤0.01%	2313
2018 Q2	$3.29M	Buy	55,100 +44,000	+396%	+$2.37M	0.01%	1403
2018 Q1	$448K	Sell	11,100 -11,300	-50%	-$551K	﹤0.01%	3587
2017 Q4	$1.18M	Sell	22,400 -3,900	-15%	-$208K	﹤0.01%	2153
2017 Q3	$1.24M	Buy	26,300 +200	+0.8%	+$8.05K	﹤0.01%	2069
2017 Q2	$923K	Buy	+26,100	New	+$806K	﹤0.01%	2305
2017 Q1	–	Sell	-30,600	Closed	-$409K	–	4285
2016 Q4	$409K	Buy	30,600 +15,500	+103%	+$250K	﹤0.01%	3051
2016 Q3	$280K	Buy	+15,100	New	+$266K	﹤0.01%	3380
2015 Q3	–	Sell	-19,500	Closed	-$580K	–	3733
2015 Q2	$580K	Buy	+19,500	New	+$490K	﹤0.01%	2133

Other funds holding EXAS

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

PRS

Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return

PWMAG

Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.46B AUM 22.77% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Jane Street's EXAS Position: Q1 2026 in Review

Jane Street sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 1,428,305 shares — an estimated $145M sold.

Jane Street first reported a position in EXAS in Q2 2013 and held it in 45 quarters. The position peaked at $145M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

Jane Street reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
Jane Street sold 1,428,305 Exact Sciences shares in Q1 2026, an estimated $145M.
Jane Street first reported a position in Exact Sciences in Q2 2013 and held it in 45 quarters.
Jane Street's Exact Sciences position peaked at $145M in Q4 2025.
7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.